Persistent Corneal Epithelial Defects Treatment Market Scope and Market Size

The increase in the number of people suffering from corneal epithelial defects across the globe acts as one of the major factor driving the growth of persistent corneal epithelial defects treatment market. The introduction of new technology development offering therapies for treating various complications caused by the disorder and rise in prevalence of dry eye syndrome accelerate the market growth. The increase in rate of acquisition strategies and company collaborations, and surge in the number of people suffering from diabetes further influence the market. Additionally, rise in geriatric population, developments in therapies, and rise in investment for research activities positively affect the persistent corneal epithelial defects treatment market. Furthermore, development of novel therapeutics extend profitable opportunities to the market players in the forecast period of 2021 to 2028.